5th International Forum on Blast Injury Countermeasures (IFBIC 2020)
Second Announcement and Call for Papers
5th International Forum on Blast Injury Countermeasures
May 11 (Mon) – 13 (Wed), 2020
Keio Plaza Hotel Tokyo (Tokyo, Japan)
Considering the current situation that the novel coronavirus is strictly controlled in Japan, the IFBIC 2020 is planned to take place as scheduled. Please pay attention to the updated information at the website.
Abstract submission deadline: February 28 (Fri), 2020
Abstract acceptance notification: March 13 (Fri), 2020
Preregistration deadline: April 10 (Fri), 2020
Hotel reservation deadline: April 24 (Fri), 2020
IFBIC 2020: May 11 (Mon) – 13 (Wed), 2020
A closed meeting for organizing committee members will be held on May 14 (Thu).
- IFBIC 2020 Second Announcement and Call for Papers
- IFBIC 2020 Abstract Template
- IFBIC 2020 Registration Form
- IFBIC 2020 Hotel Booking Form
Objective and Scope
In recent years, attacks using explosive devices occur frequently not only on battlefields and in regions of conflict but also in urban areas due to terrorism, resulting in a large number of blast injury victims. The US Department of Defense uses the Taxonomy of Injuries from Explosive Devices (DoDD 6025.21E) to organize blast injuries into five groupings. Primary injuries result from the blast shock wave. Secondary injuries result from penetrating fragments accelerated by the blast. Tertiary injuries are caused by acceleration or blunt impact to tissues. Quaternary injuries include dermal burns and toxic gas inhalation. Quinary injuries include contamination by nuclear, chemical or biological agents. Primary injuries that are peculiar to blast shock wave exposures include blast-induced traumatic brain injury (bTBI), hearing loss, ocular injury and lung injury. All body systems are vulnerable to secondary and tertiary injuries. In addition to injuries caused by blasts of explosive devices, bioeffects of repeated exposure to shock waves associated with high-overpressure weapons have also received much attention recently.
International cross-disciplinary collaboration is regarded as essential to investigate physical causes of blast injury, to characterize the vulnerability of anatomical systems and their functions to blasts and to develop the means to prevent, mitigate and treat blast injuries. Countermeasures may include personal protective equipments; weapons and vehicle systems engineered for safety; tactics, techniques and procedures (TTPs) for injury prevention; and medical interventions tailored to the specific needs of blast injuries.
This International Forum on Blast Injury Countermeasures (IFBIC) started as a Technical Information Exchange Forum between Japan and the United States, which brought together broad knowledge and expertise, and to share national experiences and evidence-based approaches for blast injuries. The previous three Japan-US Technical Information Exchange Forum on Blast Injury (JUFBI) were held in June 2016, April 2017 and May 2018 in Tokyo. At the end of JUFBI 2018, the organizing committee decided to change the name to International Forum on Blast Injury Countermeasures to reflect the expanding participation by additional nations such as Australia, Canada, Germany, South Korea and the United Kingdom. The IFBIC 2019 was held in Washington D.C. area from 8 to 10 May 2019.
These meetings have been very productive, involving active and fruitful discussions and exchange of creative ideas on a broad spectrum of blast injuries, identifying critical issues involving experimental and computational studies of blast-induced injuries, and creating new partnerships on joint research explorations to address many scientific and technical challenges facing the related field.
Building upon these successful meetings, the 5th International Forum on Blast Injury Countermeasures (IFBIC 2020) will be held from May 11 (Mon) to 13 (Wed), 2020 again in Tokyo, Japan.
The objectives for the 5th Forum include:
- Assembly of an international forum focused on multi-disciplinary science, engineering, and medicine necessary to increase our understanding of blast injury and its countermeasures from bench to bedside
- Achieving a mutual understanding of international efforts in blast injury research
- Identifying knowledge gaps requiring collaborative research
- Increasing understanding and promoting further collaboration to improve prevention, protection, clinical diagnosis, and treatment addressing the entire spectrum of blast-related injuries
The meeting agenda includes the following broad topic areas. Innovative research beyond this topic list will also be considered:
1) Blast injury epidemiology and environmental sensing of blast shockwave hazards
a) Clinical prevalence of varieties of blast injuries sorted by context, anatomy, and severity
b) Blast energy / physics / waveforms, reflections, effects of media (e.g., air vs. water vs. solid material)
c) Blast sensor engineering, test and evaluation, fidelity, usability
d) Correlation of blast sensing with clinical outcomes
e) Use of multiple sensors to reconstruct blast phenomena
2) Primary blast injury (due directly to shockwave effects)
a) Experimentally derived injury risk criteria for anatomical structures and their functions, including brain, ocular, auditory, and lung
b) Predicted incapacitation due to blast injuries (e.g., loss of neuromuscular control, reduced sensory or cognitive function, reduced respiration)
3) Secondary (penetrating ballistic fragments) and tertiary (acceleration and blunt force) blast injury
a) Experimentally derived injury risk criteria for anatomical structures and their functions
b) Predicted incapacitation due to blast injuries (e.g., loss of musculoskeletal force)
4) Long-term effects, cumulative effects, and chronic symptoms due to blast exposure
a) Brain: aberrant protein expression and accumulation (e.g., phosphorylated Tau)
b) Brain: chronic traumatic encephalopathy (CTE)-like symptoms
c) Brain: correlation and comorbidity with post-traumatic stress disorder (PTSD)
d) Effect of cumulative subclinical (i.e., not provoking diagnosis) exposures to blast phenomena for all body systems
e) Effect of repeated clinical (i.e., provoking diagnosis) exposures to blast phenomena for all body systems
5) Prevention, mitigation, treatment of blast injuries
a) Personal protective equipment (PPE) such as helmets, body armor, eye protection, hearing protection, etc.
b) Weapon and vehicle systems engineered for safety in blast environments
c) Tactics, techniques, and procedures (TTPs) for Warfighter safety in blast environments
d) Operational mission planning for needed medical response
e) Lessons learned from military operations
f) Resilience training (e.g., stress inoculation, mindfulness-based cognitive therapies to prevent sequelae of psychological trauma from blast exposures)
g) Biomedically-based design and acquisition standards for military equipment (materiel)
h) Biomedically-based health hazard assessments
i) Clinical current practices, interventions, surgeries, rehabilitative therapies
6) Diagnostic measures / biomarkers
a) Innovations in self-reported symptom inventories
b) Innovations in diagnostics based on observations by clinical staff
c) Innovations in molecular markers of blast injury
d) Innovations in biomedical imaging measures of blast injury
e) Innovations in behavioral or functional tests for blast injury
7) Computational modeling and simulation of blast phenomena and blast injury
a) Deformable finite element modeling (FEM) of stresses and strains
b) Injury risk criteria applied to force-time histories from FEM
c) Incapacitation risk criteria applied to injury predictions from FEM
d) Shockwave modeling
e) Innovations in coupling between computational fluid dynamics (CFD) and FEM
f) Integration of computational models with blast sensors and other sensors (e.g, strain gauges or force transducers on cadavers or simulant manikins)
8) Characteristics comparison between blast-related TBI and blunt TBI
9) New technology and methods for blast injury research and medicine
Contributions from all countries, as well as from young investigators, are welcome.
The 5th International Forum on Blast Injury Countermeasures (IFBIC 2020)
National Defense Medical College Japan (NDMC)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Combat Capabilities Development Command (CCDC)
Keio Plaza Hotel Tokyo (https://www.keioplaza.com)
Room: 47th Floor, Aozara（あおぞら）
2-2-1 Nishi-Shinjuku, Shinjuku-Ku, Tokyo 160-8330, Japan
Limousine bus is available between the Narita International Airport and the Keio Plaza Hotel, and between the Haneda International Airport and the Keio Plaza Hotel.
Please prepare your abstract using the template provided at the conference website. Abstract submissions should be emailed to the IFBIC 2020 secretary office no later than February 28 (Fri), 2020.
IFBIC 2020 secretary office: email@example.com
All submitted abstracts will be reviewed by the IFBIC 2020 Program Committee and notification of abstract acceptance will be made by March 13 (Fri), 2020.
Pre-registration is required for all participants, and participation will be limited by venue capacity. Please send the pre-registration form (available at the conference website) to the conference secretary office. The pre-registration deadline is April 10 (Fri), 2020.
“On-site” registration will not be offered.
For the participants who want to stay at the Forum venue, the IFBIC 2010 secretary office plans to reserve a block of rooms. Please send the hotel reservation form posted at the conference website not later than April 24 (Fri) by email or fax to the IFBIC 2020 secretary office.
Get-Together and Forum Dinner
Please join the evening get-together on May 11 (Mon), and the Forum dinner on May 12 (Tue), for more conversation, socializing, and networking. Additional information to follow.
Meeting Organization Committee
Raj Gupta.(USAMRDC, USA)
Daizoh Saitoh (NDMC, Japan)
Raj Gupta (USAMRDC, USA)
Shunichi Sato (NDMC, Japan)
James Batchelor (Univ. of Southampton, UK)
Shoko Edogawa (OTSG, USA)
Masayuki Sakamoto (ATLA, Japan)
Shashi Karna (US Army Comabt Capabilities Development Command (CCDC) Army Research Laboratory (CCDC Army Research Laboratory) , USA)
Satoko Kawauchi (NDMC, Japan)
Emrys Kirkman (DSTL, UK)
Yukihiro Nakamura (NDMC, Japan)
Izumi Nishidate (TUAT, Japan)
Kyungho Park (US Army CCDC, International Technology Center-Pacific (ITC-PAC), USA)
Nariyoshi Shinomiya (NDMC, Japan)
Richard Shoge (USAMRDC, USA)
Shuji Sue (NDMC, Japan)
Masaki Takeda (ATLA, Japan)
Akimasa Tashiro (NDMC, Japan)
Satoshi Tomura (NDMC, Japan)
Therese West (USAMRDC, USA)
Raj Gupta (USAMRDC, USA)
Kyungho Park (USArmy CCDC, ITC-PAC, USA)
Shunichi Sato (NDMC, Japan)
Izumi Nishidate (TUAT, Japan)
Division of Bioinformation and Therapeutic Systems
National Defense Medical College Research Instisute
3-2, Namiki, Tokorozawa-shi, Saitama 359-8513, Japan
Telephone: +81 (4) 2995-1379
Fax: +81 (4) 2991-1757
Conference Secretary Office:
Partners and Sponsors